Publikationer pr. år
Publikationer pr. år
Personlig profil
Expertise
Crohn’s disease; ulcerative colitis; biologic therapy; Good Clinical Practice (GCP); experience in preparing and running a multicenter clinical study.
Primære forskningsområder
Optimizing infliximab therapy in patients with inflammatory bowel disease.
Aktuel forskning
An investigator-initiated double-blind, randomized, placebo controlled, multicentre clinical trial with the aim to investigate if infliximab can safely and favourably be discontinued in patients with Crohn's disease, in sustained complete remission on infliximab maintenance therapy.
Mulige interessekonflikter
Served as speaker for Janssen
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Sine Schnoor Buhl er aktive. Disse emneetiketter kommer fra denne persons arbejder. Sammen danner de et unikt fingerprint.
- 1 Lignende profiler
Samarbejde og topforskningsområder i de sidste fem år
Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller
-
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis
Katibian, D. J., Solitano, V., Polk, D. B., Nguyen, T., Ma, C., Syal, G., Kobayashi, T., Hibi, T., Buhl, S., Ainsworth, M. A., Jairath, V. & Singh, S., jan. 2024, I: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 22, 1, s. 22-33.e6Publikation: Bidrag til tidsskrift › Review › peer review
6 Citationer (Scopus) -
A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients' and physicians' preferences and adherence
Christensen, K. R., Steenholdt, C., Buhl, S., Brynskov, J. & Ainsworth, M. A., 4 mar. 2022, I: Scandinavian Journal of Gastroenterology. 57, 3, s. 274-281 8 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
5 Citationer (Scopus) -
Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease
Buhl, S., Steenholdt, C., Brynskov, J., Christensen, K. R., Dorn-Rasmussen, M., Thomsen, O. Ø., Bendtzen, K., Klausen, T. W., Dahlerup, J. F., Thorsgaard, N., Jahnsen, J., Molazahi, A., Pedersen, N., Kjeldsen, J., Almer, S., Dahl, E. E., Vind, I., Cannon, A. G., Marsal, J. & Sipponen, T. & 7 flere, , aug. 2022, I: NEJM Evidence. 1, 8, s. EVIDoa2200061Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
-
Drug Levels Associated with Optimal Discrimination Between Remission and Non-Remission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease
Dorn-Rasmussen, M., Buhl, S., Brynskov, J., Bay, J. T., Bolstad, N., Klausen, T. W., Warren, D. J., Ainsworth, M. A. & Steenholdt, C., 1 apr. 2022, I: Therapeutic Drug Monitoring. 44, 2, s. 290-300 11 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
1 Citationer (Scopus) -
Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics
Christensen, K. R., Ainsworth, M. A., Steenholdt, C., Buhl, S., Skougaard, M., Brynskov, J., Jørgensen, T. S. & Kristensen, L. E., sep. 2022, I: Scandinavian Journal of Gastroenterology. 57, 9, s. 1051-1057 7 s.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
8 Citationer (Scopus)